| ID | 64197 |
| FullText URL | |
| Author |
Oka, Akihiro
Department of Cardiology, Kagawa Prefectural Central Hospital
Sudo, Yuya
Department of Cardiology, Kagawa Prefectural Central Hospital
Miyoshi, Toru
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
Ozaki, Masatomo
Department of Cardiology, Kagawa Prefectural Central Hospital
Kimura, Yuta
Department of Cardiology, Kagawa Prefectural Central Hospital
Takagi, Wataru
Department of Cardiology, Kagawa Prefectural Central Hospital
Ugawa, Satoko
Department of Cardiology, Kagawa Prefectural Central Hospital
Okada, Tomoaki
Department of Cardiology, Kagawa Prefectural Central Hospital
Nosaka, Kazumasa
Department of Cardiology, Kagawa Prefectural Central Hospital
Doi, Masayuki
Department of Cardiology, Kagawa Prefectural Central Hospital
|
| Abstract | Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID-19) mRNA vaccination. A 50-year-old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID-19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.
|
| Keywords | COVID-19 mRNA vaccination
fulminant myocarditis
steroid pulse therapy
|
| Published Date | 2022-02-07
|
| Publication Title |
CLINICAL CASE REPORTS
|
| Volume | volume10
|
| Issue | issue2
|
| Publisher | WILEY
|
| Start Page | e05378
|
| ISSN | 2050-0904
|
| Content Type |
Journal Article
|
| language |
English
|
| OAI-PMH Set |
岡山大学
|
| Copyright Holders | © 2022 The Authors.
|
| File Version | publisher
|
| PubMed ID | |
| DOI | |
| Web of Science KeyUT | |
| Related Url | isVersionOf https://doi.org/10.1002/ccr3.5378
|
| License | https://creativecommons.org/licenses/by-nc/4.0/
|
